Login
← Go Back
Lupin
LUPIN · Pharma > Pharmaceuticals & Drugs · Chairman: Manju D Gupta · MD: Nilesh Gupta · Listing date: Sept. 11, 2001 · Employees: 18573 · Mumbai · http://www.lupin.com
Stock Price vs Company Growth
1d
0.4%
1w
0.8%
1m
0.6%
3m
0.6%
6m
7.3%
1y
17.4%
5y
14.9%
10y
5.1%
all
16.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,267 0.4%
2,172
2,492
Company Overview
Sales
27,958 Cr
Growth: 18.1%
Profit after Tax
5,333 Cr
Growth: 14.8%
Large Cap
1,03,645 Cr
P/E: 19.5x
Industry P/E: 31.3x
Fundamentals
Sales (Cr) ₹ 27,958
Growth 18.1%
EBITDA 31.5%
P/S 3.7x
Dividend 0.6%
P/E 19.5x
Book Value ₹ 491
PEG Ratio 1.1x
ROE 26.1%
P/B 4.6x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
6.99 %
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund
4.28 %
Government Pension Fund Global
1.21 %
Franklin India Focused Equity Fund
1.13 %
Icici Prudential Life Insurance Company Limited
1.13 %
Promoters
Lupin Investments Pvt Ltd
45.3 %
Manju D Gupta
0.85 %
Nilesh D Gupta
0.2 %
Anuja Gupta
0.16 %
Desh Bandhu Gupta Huf
0.14 %
Others
Rakesh Jhunjhunwala
1.6 %
Nps Trust - A/C Lic Pension Fund Sch-State Govt
1.48 %
Iepf
0.15 %
Increase    Decrease    No change
Company Profile Detailed
Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in many markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S.
Belongs to (51 Indices) view more
Investors (233)
lavneet
ishares....
goldman....
Followers (56)
rehan
yogesh
nitin2